GGrantIndex
← Leaderboards

Alfred Lm Bothwell

University Of Arizona

$9,528,535
Attributed
$10,758,333
Total exposure
9
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY200823
$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$10,758,333 · 9

By mechanism

R01$9,233,438 · 5
R21$1,106,145 · 3
R56$418,750 · 1

Top collaborators

Others in their field

Top investigators on “In Vivo

Research focus

In VivoMediatingImmune SystemIn VitroLeadT-LymphocyteCellsPathway InteractionsSignal TransductionAffectSourceCytokineResponseCd4 Positive T LymphocytesImmune ResponseImmuneInterleukin-10PreventReceptorCell TypeRegulatory T-LymphocyteBaseInflammatoryLymphocyte

Grant awards (32)

Thrombocyte Regulation of Anti-Parasite Immunity$300,938
R01 · FY2023 · AI · contact PI
Thrombocyte Regulation of Anti-Parasite Immunity$82,812
R01 · FY2023 · AI · contact PI
Thrombocyte Regulation of Anti-Parasite Immunity$383,750
R01 · FY2022 · AI · contact PI
Thrombocyte Regulation of Anti-Parasite Immunity$418,750
R01 · FY2021 · AI · contact PI
Thrombocyte Regulation of Anti-Parasite Immunity$418,750
R01 · FY2020 · AI · contact PI
Thrombocyte Regulation of Anti-Parasite Immunity$418,750
R01 · FY2019 · AI · contact PI
Regulatory T Cell Control of Intestinal Tumorigenesis$345,488
R01 · FY2018 · CA · contact PI
Regulation of Pulmonary Inflammation in Asthma by Wnt Antagonist DKK1$209,375
R21 · FY2018 · AI · contact PI
Regulatory T Cell Control of Intestinal Tumorigenesis$41,075
R01 · FY2018 · CA · contact PI
Thrombocyte Regulation of Anti-Parasite Immunity$418,750
R56 · FY2017 · AI · contact PI
Regulatory T Cell Control of Intestinal Tumorigenesis$345,488
R01 · FY2017 · CA · contact PI
Regulation of Pulmonary Inflammation in Asthma by Wnt Antagonist DKK1$251,250
R21 · FY2017 · AI · contact PI
Regulatory T Cell Control of Intestinal Tumorigenesis$126,184
R01 · FY2017 · CA · contact PI
Regulatory T Cell Control of Intestinal Tumorigenesis$345,488
R01 · FY2016 · CA · contact PI
Regulatory T Cell Control of Intestinal Tumorigenesis$126,184
R01 · FY2016 · CA · contact PI
Regulatory T Cell Control of Intestinal Tumorigenesis$345,488
R01 · FY2015 · CA · contact PI
Regulatory T cell control of intestinal tumorigenesis$80,544
R01 · FY2015 · CA · contact PI
Regulating Anti-Endothelial T Cell Responses in Graft Arteriosclerosis$610,733
R01 · FY2014 · HL
Regulatory T Cell Control of Intestinal Tumorigenesis$345,488
R01 · FY2014 · CA · contact PI
Regulatory T cell mediated control of colitis by Dkk1$208,125
R21 · FY2014 · AI · contact PI
Regulating Anti-Endothelial T Cell Responses in Graft Arteriosclerosis$595,628
R01 · FY2013 · HL
Regulatory T cell mediated control of colitis by Dkk1$234,706
R21 · FY2013 · AI · contact PI
Regulating Anti-Endothelial T Cell Responses in Graft Arteriosclerosis$626,288
R01 · FY2012 · HL
Regulating Anti-Endothelial T Cell Responses in Graft Arteriosclerosis$626,947
R01 · FY2011 · HL
PPAR-Mediated Inhibition of Vascular Remodeling$413,750
R01 · FY2011 · HL · contact PI
PPAR-Mediated Inhibition of Vascular Remodeling$413,750
R01 · FY2010 · HL · contact PI
Generation of Synthetic Human Islet Microorgans$329,165
R01 · FY2010 · DK · contact PI
PPAR-Mediated Inhibition of Vascular Remodeling$413,750
R01 · FY2009 · HL · contact PI
Generation of Synthetic Human Islet Microorgans$332,490
R01 · FY2009 · DK · contact PI
PPAR-Mediated Inhibition of Vascular Remodeling$413,438
R01 · FY2008 · HL · contact PI
Generation of Synthetic Human Islet Microorgans$332,322
R01 · FY2008 · DK · contact PI
Revascularization of Islets to Treat Type I Diabetes$202,689
R21 · FY2008 · AI · contact PI